NASA’s X-59 returned early from its second test flight after a return-to-base call as the pilot and aircraft landed safely at Edwards Air Force base in California.

In February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million, sharply higher than a year earlier, while its quarterly net loss narrowed to US$108.12 million and ...

Add Yahoo as a preferred source to see more of our stories on Google. As pet parents, to help decode these cat communication signals, Dr. Hunt reveals some of the heartwarming things cats say with ...

Operator: Good morning, and welcome to the Otter Tail Corporation Fourth Quarter 2025 Earnings Conference Call. Today’s call is being recorded. We will hold a question-and-answer session after the ...

Otter Tail Corporation (Nasdaq: OTTR) will issue a news release announcing 2025 financial results after the stock market closes on Monday, February 16, 2026 and will host a live conference call and ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...